Shares of Merck KGaA (ETR:MRK – Get Free Report) were down 1.4% on Thursday . The stock traded as low as €142.25 ($145.15) and last traded at €143.00 ($145.92). Approximately 227,393 shares changed hands during mid-day trading, The stock had previously closed at €145.00 ($147.96).
Merck KGaA Price Performance
The company has a debt-to-equity ratio of 37.56, a quick ratio of 0.72 and a current ratio of 1.31. The business has a 50 day moving average price of €142.94 and a 200-day moving average price of €154.76. The company has a market capitalization of $18.42 billion, a price-to-earnings ratio of 23.60, a P/E/G ratio of 2.37 and a beta of 0.71.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Further Reading
- Five stocks we like better than Merck KGaA
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Options Trading – Understanding Strike Price
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- How to Invest in Blue Chip Stocks
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
